Yu Li
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Fibroblast Growth Factor Research 13
- Epidemiology 64
- Liver Disease Diagnosis and Treatment 26
- Autophagy in Disease and Therapy 13
- Adipokines, Inflammation, and Metabolic Diseases 11
- Co-authors
- Kimberly G. Blumenthal (6 shared papers)Mengwei Zang (8 shared papers)Aoyuan Cui (16 shared papers)David J. Waxman (2 shared papers)Thomas K. H. Chang (2 shared papers)Roberto D. Polakiewicz (3 shared papers)Xiao‐Jian Sun (3 shared papers)Zhengshuai Liu (11 shared papers)
- Journals
- Hepatology (8 papers)Diabetes (7 papers)Journal of Biological Chemistry (6 papers)Scientific Reports (6 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yu Li
317 papers receiving 10.4k citations
Yu Li's Hit Papers
Peers
Comparison fields: 5 of 174
- Geriatrics and Gerontology 377
- Pharmacology 686
- Aging 122
- Epidemiology 1.9k
- Pharmacology 926
Countries citing papers authored by Yu Li
This map shows the geographic impact of Yu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Li more than expected).
Fields of papers citing papers by Yu Li
This network shows the impact of papers produced by Yu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Li. The network helps show where Yu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 335 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 364 | |
| 2 | 2000 | 358 | |
| 3 | The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk Hit paper breakdown → | 2017 | 313 |
| 4 | Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection Hit paper breakdown → | 2017 | 304 |
| 5 | 2004 | 276 | |
| 6 | 2003 | 275 | |
| 7 | 2019 | 266 | |
| 8 | 2011 | 251 | |
| 9 | 2013 | 241 | |
| 10 | 2019 | 209 | |
| 11 | 2009 | 208 | |
| 12 | 2011 | 192 | |
| 13 | 2020 | 171 | |
| 14 | Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. | 1997 | 168 |
| 15 | 2018 | 166 | |
| 16 | 2014 | 164 | |
| 17 | 2016 | 142 | |
| 18 | 2017 | 126 | |
| 19 | 2017 | 125 | |
| 20 | 2019 | 118 |
About Yu Li
Yu Li is a scholar working on Molecular Biology, Epidemiology, Pharmacology, Surgery and Cell Biology, having authored 335 papers that have together received 10.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (26 papers), Endoplasmic Reticulum Stress and Disease (15 papers), Autophagy in Disease and Therapy (13 papers), Fibroblast Growth Factor Research (13 papers), Adipose Tissue and Metabolism (11 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers), Pancreatic function and diabetes (10 papers) and Fungal Biology and Applications (10 papers). The work is most often cited by research in Geriatrics and Gerontology (377 citations), Pharmacology (686 citations), Aging (122 citations), Epidemiology (1.9k citations) and Pharmacology (926 citations). Yu Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kimberly G. Blumenthal, Mengwei Zang, Aoyuan Cui, David J. Waxman, Thomas K. H. Chang, Roberto D. Polakiewicz, Xiao‐Jian Sun, Zhengshuai Liu, Bin Gao and Yamei Han. Their work appears in journals such as Hepatology, Diabetes, Journal of Biological Chemistry, Scientific Reports and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.